Chargement en cours...
Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials
Aliskiren is the newest antihypertensive drug and the first orally active direct renin inhibitor to become available for clinical use. Clinical data have substantiated that the antihypertensive effectiveness of aliskiren is similar to that of the other major antihypertensive agents. Furthermore, ali...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3752183/ https://ncbi.nlm.nih.gov/pubmed/23997927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622313495288 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|